0001209191-11-034520.txt : 20110614 0001209191-11-034520.hdr.sgml : 20110614 20110614154251 ACCESSION NUMBER: 0001209191-11-034520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110612 FILED AS OF DATE: 20110614 DATE AS OF CHANGE: 20110614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arora Krishan K CENTRAL INDEX KEY: 0001493973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 11910643 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-06-12 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001493973 Arora Krishan K 11500 S. EASTERN AVENUE SUITE 240 HENDERSON NV 89052 1 0 0 0 Stock Option (Right to Buy) 8.27 2011-06-12 4 A 0 50000 0.00 A 2021-06-12 Common Stock 50000 50000 D 25% of the option shares vested on June 12, 2011. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. /s/ Shyam Kumaria, attorney-in-fact for Krishan Arora 2011-06-14 EX-24.4_382507 2 poa.txt POA DOCUMENT POWER OF ATTORNEY AUTHORIZATION I hereby authorize Shyam Kumaria or Rajesh Shrotriya, acting singly, to sign and file on my behalf any and all forms required by the Securities and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the reporting of beneficial ownership of equity securities of Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and of changes in such beneficial ownership, together with any and all amendments thereto. This authorization shall be effective on and after the date set forth below and shall continue in effect until I am no longer required to file such forms, unless earlier revoked by me in writing. I acknowledge that the persons authorized hereunder are not assuming, nor is the Company assuming, any of my responsibilities to comply with Section 16 of the Exchange Act. Dated as of this 10th day of June, 2010. /s/ Krishan Arora Krishan Arora, Ph.D.